PharmaCyte Biotech, Inc. 8-K/A
Accession 0001683168-25-008512
Filed
Nov 17, 7:00 PM ET
Accepted
Nov 18, 4:05 PM ET
Size
2.2 MB
Accession
0001683168-25-008512
Documents
- 8-Kpharmacyte_8ka.htm
8-K/A
- EX-23.1pharmacyte_ex2301.htm
CONSENT OF STEPHANO SLACK LLC, INDEPENDENT AUDITOR OF Q/C
- EX-23.2pharmacyte_ex2302.htm
CONSENT OF MORISON COGEN LLP, INDEPENDENT AUDITOR OF Q/C
- EX-99.1pharmacyte_ex9901.htm
Q/C AUDITED CONSOLIDATED FINANCIAL STATEMENTS AS OF DECEMBER 31, 2024 AND 2023, AND FOR THE YEARS ENDED DECEMBER 31, 2024 AND 2023, TOGETHER WITH THE NOTES THERETO AND REPORTS OF INDEPENDENT AUDITORS THEREON.
- EX-99.2pharmacyte_ex9902.htm
Q/C UNAUDITED CONDENSED CONSOLIDATED FINANCIAL STATEMENTS AS OF JUNE 30, 2025, AND FOR THE SIX MONTHS ENDED JUNE 30, 2025, TOGETHER WITH THE NOTES THERETO.
- EX-99.3pharmacyte_ex9903.htm
UNAUDITED PRO FORMA CONDENSED COMBINED FINANCIAL INFORMATION
- EX-101.SCHpmcb-20250902.xsd
XBRL SCHEMA FILE
- EX-101.LABpmcb-20250902_lab.xml
XBRL LABEL FILE
- EX-101.PREpmcb-20250902_pre.xml
XBRL PRESENTATION FILE
- XMLR1.htm
IDEA: XBRL DOCUMENT
- XMLShow.js
IDEA: XBRL DOCUMENT
- XMLreport.css
IDEA: XBRL DOCUMENT
- XMLFilingSummary.xml
IDEA: XBRL DOCUMENT
- JSONMetaLinks.json
IDEA: XBRL DOCUMENT
- ZIP0001683168-25-008512-xbrl.zip
IDEA: XBRL DOCUMENT
- XMLpharmacyte_8ka_htm.xml
IDEA: XBRL DOCUMENT
Issuer
PharmaCyte Biotech, Inc.
CIK 0001157075
Related Parties
1- filerCIK 0001157075
Filing Metadata
- Form type
- 8-K/A
- Filed
- Nov 17, 7:00 PM ET
- Accepted
- Nov 18, 4:05 PM ET
- Size
- 2.2 MB